We have cloned a type I serine/threonine kinase receptor, XTrR-I, from Xenopus. XTrR-I (Xenopus transforming growth factor 8-related receptor type I) is expressed in all regions of embryos throughout early development. Overexpression of this receptor does not affect ectoderm or endoderm but dorsalizes the mesoderm such that muscle appears in ventral mesoderm and notochord appears in lateral mesoderm normally fated to become muscle. In addition, overexpression of XTrR-I in UV-treated embryos is able to cause formation of a partial dorsal axis. These results suggest that XTrR-I encodes a receptor which responds in
opment. Overexpression of this receptor does not affect ectoderm or endoderm but dorsalizes the mesoderm such that muscle appears in ventral mesoderm and notochord appears in lateral mesoderm normally fated to become muscle. In addition, overexpression of XTrR-I in UV-treated embryos is able to cause formation of a partial dorsal axis. These results suggest that XTrR-I encodes a receptor which responds in normal development to a transforming growth factor 13-like ligand so as to promote dorsalization. Its function would therefore be to direct mesodermalized tissue into muscle or notochord.
The body plan of the early Xenopus embryo is achieved by a number of inductive interactions, thought to be mediated by a variety of,soluble growth factors (for reviews see refs. 1 and 2).
The first of these inductions is believed to form the mesoderm by an interaction between the animal and vegetal pole regions of a blastula, a process first described by Nieuwkoop (3) . This induction may be mimicked in vitro by treating isolated animal caps with purified growth factors. Such "animal cap assays" have identified two classes of candidate molecules as mesoderm inducers. These are members of the fibroblast growth factor (FGF) family, in particular basic FGF (bFGF) (4, 5) , and members of the transforming growth factor 1B (TGF-,3) family, notably activin (6, 7) and Vgl (8) (9) (10) . The mesoderm is patterned by a second inductive interaction, first suggested by the organizer graft experiments originally performed by Spemann and Mangold (11) . More recent experiments have shown that the organizer region of an embryo is able to dorsalize ventral mesoderm (12, 13) and that this dorsalization is achieved by means of a secreted growth factor (14) . At present, there is only one candidate molecule for this dorsalizing factor in Xenopus, the secreted protein noggin (15) . In addition to a dorsalizing signal, there is evidence that ventralizing signals may also be important in the correct patterning of the mesoderm. Bone morphogenetic protein 4 (BMP-4), a member of the TGF-,B family, was shown to ventralize embryos when its mRNA was injected into fertilized eggs (16, 17) .
Recent work has shown that the receptors for members of the TGF-f3 family are transmembrane serine/threonine ki- MATERIALS AND METHODS PCR Cloning of XTrR-I. The DNA template used for PCR amplification was aXenopus stage 9 embryo cDNA library (gift of C. R. Sharpe and P. Lemaire; University of Cambridge) that had been partially subtracted with Xenopus egg RNA (27) . Degenerate PCR primers were constructed from analysis of known serine/threonine kinase receptors that correspond to kinase domains II, VI, and VIII (28) . A semi-nested PCR approach was used, employing a single 5' primer, primer A, in both amplifications and two 3' primers, primer B in the first amplification and primer C in the second amplification. Primer inserted into pBluescript KS (Stratagene). Clones were then sequenced (29) by using the Sequenase 2.0 kit (United States Biochemical). One of the clones, RST 2, showed a previously unreported sequence and was used for isolation of a full-length cDNA.
A stage 24/26 library (gift of N. Garrett and P. Lemaire, Wellcome/CRC Institute) was screened by using a randomprimed probe (30) made from the subcloned PCR product, RST 2. Library screening was carried out as described (31) . A 2.02-kb clone was isolated and sequenced at least twice on both strands. Sequence analysis was performed by using the University of Wisconsin Genetics Computer Group package. The coding sequence of XTrR-I was inserted into pBluescriptRN3 (32) , in such a way as to generate an appropriate construct for the synthesis of in vitro transcribed mRNA for injection into embryos.
Embryo Manipulations and mRNA Microinjections. Embryos were in vitro fertilized, dejellied, and cultivated as described (33) . U.V. ventralized embryos were obtained by irradiating their vegetal poles in an inverted Stratalinker (Stratagene) 20-25 min after fertilization. For microinjection, embryos were transferred to 4% Ficoll-400 (Pharmacia) in 1 x modified Barth's saline (33) , and injected with either 4.6 or 9.2 nl of mRNA solution by using a Drummond (Broomall, PA) Nanoject microinjector. Synthetic, capped mRNA was prepared by using the T3 and SP6 Ambion (Austin, TX) Megascript in vitro transcription kits.
RNase Protection Assays. RNase protection assays were performed as described (34) . The FGF receptor and Xbra probes were those used before (34) . The XTrR-I probe was derived from the subcloned PCR product originally isolated. The protected fragment was 318 nt long.
Antibody Staining of Xenopus Embryos. Embryo fixation and antibody staining were performed as described (35) . Muscle staining was carried out with the 12/101 antibody (36) , and notochord staining was carried out with the MZ 15 antibody (37).
RESULTS
Cloning and Sequencing of XTrR-I. We have used a degenerate PCR procedure to clone serine/threonine kinase receptors. The choice of primer sequences was based on that of known serine kinase receptors (18) . We employed a seminested strategy, such that the 5' primer was specific to this class of receptors and was used in both rounds of amplification, while the two 3' primers were from kinase domains VI and VIII, which are conserved between many serine kinases (28) . The starting DNA template was a Xenopus laevis stage 9 embryo cDNA library which had been partially subtracted with egg RNA (27) , such that sequences expressed in eggs were reduced and those expressed more strongly at stage 9 (Fig. 1) showed it to have a signal peptide, a cysteine-rich extracellular domain containing a putative Nglycosylation site, a putative transmembrane domain, and a serine kinase domain. Data-base analysis (39) showed that this clone has a significant homology to the human type I receptor for TGF-,B T,BR-1 (40) , and to the human type I receptor for activin, ActR-IB (41 XTrR-I Is Expressed Throughout Early Development. We determined by RNase protection that XTrR-I mRNA is present throughout early development (Fig. 2a) at a level similar to that of the FGF receptor, which has been found by others to be present at a constant level from egg to tail bud (43) . Using dissected regions of early embryos (Fig. 2 b and c) , we conclude that XTrR-I mRNA is not spatially restricted at the early gastrula stage.
Ectopic Expression of XTrR-I Increases Dorsal Gene Expression in Whole Embryos. To investigate the role of XTrR-I in development, we expressed the receptor ectopically by injecting synthetic XTrR-I messenger RNA into 2-or 4-cell embryos. We injected either receptor mRNA or 13-galactosidase mRNA as a control into the animal, equatorial, or vegetal regions of a 2-cell embryo, isolated these regions at the midblastula stage, and cultured them separately until the early gastrula stage (stage 10.5; ref. 38). X-brachyury, an early mesodermal marker, was expressed only in the equatorial tissue (data not shown). We can therefore conclude that overexpression of the receptor mRNA does not divert the ectoderm or endoderm cells from their normal fate toward mesoderm, as judged by X-brachyury expression, nor does it change the total amount of mesodermal differentiation of equatorial cells.
This raises the question of whether the fate of cells within the mesoderm-i.e., the notochord, muscle, etc.-is affected by overexpression of the receptor. We might well expect an effect of this kind since signaling is believed to be involved in mesoderm formation. In particular, two processes have been proposed for mesoderm patterning during gastrulation, namely dorsalization (14) and a community effect (33, 44) , and both are thought to be mediated by secreted signaling molecules. Increasing the abundance of a receptor for such patterning factors might increase the sensitivity of cells to a particular concentration of factor and so affect the type of mesoderm formed.
In the first experimental series, 4-cell embryos were injected with 6 ng of XTrR-I mRNA in the ventral equatorial region, a region whose normal fate is to form ventral mesoderm but not muscle or notochord. Injected embryos were cultured until stage 32 and then stained with either 12/101 antibody, a marker of terminal muscle differentiation (36) or MZ 15, a notochord marker (37) . Fig. 3 a and b shows the 12/101-stained embryos; it can be seen that those injected with XTrR-I mRNA have an ectopic expression of the muscle marker in the ventral region of the embryo compared with the controls, which show the expected staining solely in the somites. Fig. 3c is a section of an injected embryo and shows that the muscle staining in the ventral region of the embryo is in the mesoderm layer and not in the endoderm. Staining with MZ 15 revealed no ectopic notochord staining (data not shown).
In a second series of experiments, 6 ng of XTrR-I mRNA was injected into the lateral region of a 2-cell embryo, a region normally fated to form muscle. These embryos were cultured until stage 32 and expression of both muscle and notochord markers analyzed. Fig. 4a shows a marked increase in the size of the notochord in the XTrR-I mRNA-injected embryos stained with MZ 15. This is more evident when these embryos are sectioned (Fig. 4 b and c) . In some cases, 12/101 staining revealed an increase in the amount of muscle (data not shown).
Quantitative data for these injection experiments are summarized in Tables 1 and 2 . After ventral injection with XTrR-I mRNA, 72% of the embryos show ectopic expression of muscle in the ventral region of the embryo (Table 1 ). In addition, 63% of the embryos injected with XTrR-I mRNA in the prospective lateral mesoderm region show a larger notochord than do control embryos ( Table 2 ). The size of notochord was measured after sectioning, and the largest cross-sectional area of notochord scored for each embryo. A larger notochord was defined as being at least 20% larger than that of control embryos. In all cases, the length of the notochord was approximately equal to that of controls, and so any increase in cross-sectional area indicated a genuine increase in volume of the notochord and not simply a reduction in length. On average, injected embryos have notochords that are 40% larger in cross-sectional area than those ofcontrol embryos ( Table 2) . Many of the samples that did not satisfy the criterion for a larger notochord showed an increase in the amount of muscle. In conclusion, XTrR-I overexpression in prospective mesoderm tissue causes an increase in the expression of dorsal mesoderm markers. It is important to note that we never see any axis duplication, which has been reported for overexpression of the Xenopus activin receptor XActRIIB under similar experimental conditions (25) . We propose that overexpression of the receptor enhances the sensitivity of cells to dorsalizing or community-effect factors, and so causes an increased formation of dorsal structures.
XTrR-I Partially Rescues UV-Ventralized Embryos. To analyze the effect of overexpression of XTrR-I on UV-treated embryos, which are completely ventralized (45), we injected 6 ng of XTrR-I mRNA into the vegetal pole of a 2-cell embryo that had been irradiated with ultraviolet light 25 min after fertilization. Fig. 5a shows the effect of UV irradiation alone, resulting in a ventralized embryo that has no axis and no dorsal structures. In this experiment the average dorsoanterior index (DAI; see ref. 45 ) of UV-treated embryos was scored as 0.05 (n = 59). XTrR-I causes a partial rescue of the UV-treated embryos (Fig. 5b) , scoring an average DAI of 1 (n = 26). Control embryos that had not been treated with UV had an average DAI of 5 (n = 10) and were completely wild type (Fig.  5c) . In a second set of experiments, we compared the rescuing ability of XTrR-I with that of the activin type II receptor XActRIIB. In this experiment XTrR-I showed a partial rescue similar to that observed previously, but the activin receptor was unable to cause even a partial rescue and resulted in a DAI of 0 (n = 10). Although the rescue by XTrR-I is not complete, XTrR-I is certainly able to cause the formation of a dorsal axis when compared with uninjected UV-treated embryos.
DISCUSSION
XTrR-I is functionally as well as structurally different from other TGF-sf3 class receptors so far described. Overexpression of either of the two activin type II serine/threonine kinase receptors results in gastrulation defects and occasionally in an axis duplication (24, 25) . Overexpression of the BMP-4 type I receptor has been reported not to affect the early development of Xenopus embryos (46) , and injection of a truncated version of the BMP-4 receptor into the ventral side of embryos causes an axis duplication (26, 46) . In contrast, overexpression of XTrR-I seems to cause a change in cell fate, resulting in dorsalization of mesodermal cell types. This is an effect of receptor overexpression not previously observed by the injection of other receptor mRNAs in Xenopus or other species.
We have not identified a ligand for XTrR-I. We would expect this to be a member of the TGF-13 family in view of the sequence composition of XTrR-I. The only good candidate for a dorsalizing factor in Xenopus is noggin (15) , but this has no homology to any known proteins.
Most type I serine/threonine kinase receptors bind ligand poorly on their own, and bind best to a preformed ligand-type II receptor complex (20) . Thus, to assay a particular ligand for binding to a type I receptor, it may be necessary to coexpress an appropriate type II receptor. We have investigated the possibility that TGF-,B1 is a ligand for XTrR-I by using radiolabeled ligand in a cross-linking receptor-binding assay (data not shown). When XTrR-I is cotransfected with a mammalian type II receptor for TGF-,B (47), we observe only one cross-linked complex corresponding to the type II receptor; this indicates that the XTrR-I was unable to bind TGF-f31 in this assay.
XTrR-I mRNA is expressed throughout early development and is therefore present at the time that mesoderm induction and patterning take place. The overexpression data strongly suggest that this receptor plays a role in dorsoventral patterning of the embryo. We have constructed a dominant-negative mutant of XTrR-I by deleting its intracellular kinase domain.
Expression of RNA from this mutant in induced animal caps reduces dorsal structures (results not shown), which supports our view that this receptor has a function in development. Specifically, we propose that XTrR-I is involved in mediating a dorsalizing signal important for patterning of the mesoderm in vivo.
